
Intrapatient Intermetastatic Heterogeneity Determined by Triple-Tracer PET Imaging in mCRPC Patients and Correlation to Survival: The 3TMPO Cohort Study
<a href="https://news.google.com/rss/articles/CBMiekFVX3lxTE9PbmFiU2JUMDNQTzcwd255NlFjOG5md00tM0gwRHI0Qy16cGlrYTRHLURQVFFJMmRXUDREVkYzTWYxMURRTS1NNVZLOUNYek9OYl9QMWwyNUdxWk5DZ1g3WVNIWmtlRU9NQ1BrVV91aTRVZ2FEUzMtc0ln?oc=5" target="_blank">Intrapatient Intermetastatic Heterogeneity Determined by Triple-Tracer PET Imaging in mCRPC Patients and Correlation to Survival: The 3TMPO Cohort Study</a>&nbsp;&nbsp;<font color="#6f6f6f">Journal of Nuclear Medicine</font>